These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6721985)

  • 81. The disposition of diphenhydramine and four of its analogues in rabbits and implication for structure-activity relationship studies in drug design.
    Parry R; Calvert RT
    Biopharm Drug Dispos; 1982; 3(3):255-65. PubMed ID: 7139065
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prednisolone pharmacokinetics in relation to dose.
    Rose JQ; Jusko WJ; Nickelsen JA; Green OC
    J Pediatr; 1979 Jun; 94(6):1014-5. PubMed ID: 448518
    [No Abstract]   [Full Text] [Related]  

  • 83. Effect of surgical operation on the plasma clearance of infused prednisolone.
    CAMPBELL DW; MARKS LJ; KARGER R
    Ann Surg; 1960 Jul; 152(1):22-8. PubMed ID: 13807241
    [No Abstract]   [Full Text] [Related]  

  • 84. Sex-based differences in the response to dexamethasone in bacterial meningitis: Analysis of the European dexamethasone in adulthood bacterial meningitis study.
    Dias SP; Brouwer MC; van de Beek D
    Br J Clin Pharmacol; 2020 Feb; 86(2):386-391. PubMed ID: 31692016
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.
    Ghareeb M; Akhlaghi F
    Bioanalysis; 2015; 7(8):1037-58. PubMed ID: 25966013
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.
    Bergmann TK; Barraclough KA; Lee KJ; Staatz CE
    Clin Pharmacokinet; 2012 Nov; 51(11):711-41. PubMed ID: 23018468
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients.
    Barraclough KA; Isbel NM; McWhinney BC; Ungerer JP; Medley G; Johnson DW; Hawley CM; Leary DR; Campbell SB; Staatz CE
    Eur J Clin Pharmacol; 2011 Dec; 67(12):1243-52. PubMed ID: 21656211
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gender aspects of treatment and drug related toxicity in medical oncology.
    Marosi C
    Wien Med Wochenschr; 2006 Oct; 156(19-20):534-40. PubMed ID: 17103290
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacokinetic considerations in the treatment of inflammatory bowel disease.
    Schwab M; Klotz U
    Clin Pharmacokinet; 2001; 40(10):723-51. PubMed ID: 11707060
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race.
    Magee MH; Blum RA; Lates CD; Jusko WJ
    J Clin Pharmacol; 2001 Nov; 41(11):1180-94. PubMed ID: 11697751
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gender differences in pharmacokinetics.
    Gleiter CH; Gundert-Remy U
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):123-8. PubMed ID: 8839685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Gender effects in pharmacokinetics and pharmacodynamics.
    Harris RZ; Benet LZ; Schwartz JB
    Drugs; 1995 Aug; 50(2):222-39. PubMed ID: 8521756
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.
    Rollin C; Chosidow O; Diquet B; Dutreuil C; Herson S; Revuz J; Delchier JC
    Eur J Clin Pharmacol; 1993; 44(4):395-9. PubMed ID: 8513854
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Lew KH; Ludwig EA; Milad MA; Donovan K; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1993 Oct; 54(4):402-14. PubMed ID: 8222483
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
    Meffin PJ; Wing LM; Sallustio BC; Brooks PM
    Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cortisol does not inhibit prednisolone clearance.
    Meffin PJ; Sallustio BC; Purdie YJ; Robson RA; Wing LM; Brooks PM
    Br J Clin Pharmacol; 1985 Oct; 20(4):414-6. PubMed ID: 4074609
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man.
    Edsbäcker S; Andersson KE; Ryrfeldt A
    Eur J Clin Pharmacol; 1985; 29(4):477-81. PubMed ID: 3912192
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.
    Arnold M; Schrieber L; Brooks P
    Drugs; 1988 Sep; 36(3):340-63. PubMed ID: 3056693
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical pharmacokinetics of prednisone and prednisolone.
    Frey BM; Frey FJ
    Clin Pharmacokinet; 1990 Aug; 19(2):126-46. PubMed ID: 2199128
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.